This article is more than 5 years old. Information may no longer be current.

Carl Zeiss Meditec laser granted FDA approval for myopia correction

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

JENA, Germany — The Food and Drug Administration has approved Carl Zeiss Meditec's MEL 80 excimer laser system for marketing in the United States for treatment of myopia, the company announced.

The MEL 80 laser uses a small spot size and a Gaussian beam profile to create even ablations that protect surrounding tissue, according to a press release.

In clinical trials of the device, 93% of patients achieved 20/20 or better visual acuity at 3 months' follow-up, and 85% were within 0.5 D of the intended refraction, according to the release.

The press release did not specify the treatment range for which the laser was approved.